Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis

BACKGROUND: This paper aims to compare the efficacy and safety of recombinant human endostatin combined with chemotherapy in patients with squamous cell lung cancer (SqCLC). METHODS: We searched the Cochrane Library, PubMed, Embase, CNKI, Wanfang database, Metstr, VIP, and others and manually search...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Li, Wang, Zhicong, Jing, Li, Zhou, Zhiguo, Shi, Shuai, Deng, Ruoying, Liu, Yibing, Meng, Qingju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912552/
https://www.ncbi.nlm.nih.gov/pubmed/33637113
http://dx.doi.org/10.1186/s12957-021-02161-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912552/
https://www.ncbi.nlm.nih.gov/pubmed/33637113
http://dx.doi.org/10.1186/s12957-021-02161-1

Ejemplares similares